Screening populations at high risk for soft tissue sarcoma and surveillance following soft tissue sarcoma resection

Russell G Witt; Elizabeth H Baldini; Chandrajit P Raut

doi:10.1002/jso.25676

Screening populations at high risk for soft tissue sarcoma and surveillance following soft tissue sarcoma resection

J Surg Oncol. 2019 Oct;120(5):882-890. doi: 10.1002/jso.25676. Epub 2019 Aug 21.

Authors

Russell G Witt¹, Elizabeth H Baldini², Chandrajit P Raut¹

Affiliations

¹ Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
² Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

PMID: 31432526
DOI: 10.1002/jso.25676

Abstract

Soft tissue sarcomas (STS) are a rare and diverse group of tumors that affect both adult and pediatric populations. This review discusses current screening recommendations for populations at increased risk for STS, including those with genetic predispositions. We also review surveillance guidelines for those at risk for recurrence following curative-intent surgery.

Keywords: diagnostic screening programs; hereditary neoplastic syndromes; sarcoma; surveillance guidelines; surveillance imaging.

Publication types

Review

MeSH terms

Early Detection of Cancer / methods*
Genetic Predisposition to Disease*
Humans
Neoplasm Recurrence, Local / diagnosis*
Neoplasm Recurrence, Local / epidemiology
Population Surveillance*
Postoperative Care*
Prevalence
Risk Factors
Sarcoma / epidemiology
Sarcoma / genetics
Sarcoma / surgery*